Oric Pharmaceuticals (ORIC)

• Market cap: $1.08B
• 1 day: -2.03%
• 5 days: 7.66%
• 1 month: -4.48%
• 3 months: -3.31%
• 6 months: 16.72%
• Year to date: 35.86%
• 1 year: 48.59%
• 5 years: -68.92%
• 10 years: -56.93%
• Sector: Healthcare
• Industry: Biotechnology

About: ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Employees: 106